Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Investing Activities: 2023-2024

Historic Cash from Investing Activities for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to -$59.5 million.

  • Upstream Bio's Cash from Investing Activities rose 3319.87% to $48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$110.5 million, marking a year-over-year decrease of 3.64%. This contributed to the annual value of -$59.5 million for FY2024, which is 28.19% up from last year.
  • Per Upstream Bio's latest filing, its Cash from Investing Activities stood at -$59.5 million for FY2024, which was up 28.19% from -$82.8 million recorded in FY2023.
  • In the past 5 years, Upstream Bio's Cash from Investing Activities registered a high of -$59.5 million during FY2024, and its lowest value of -$82.8 million during FY2023.
  • Its 2-year average for Cash from Investing Activities is -$71.2 million, with a median of -$71.2 million in 2023.
  • Data for Upstream Bio's Cash from Investing Activities shows a peak YoY grew of 28.19% (in 2024) over the last 5 years.
  • Upstream Bio's Cash from Investing Activities (Yearly) stood at -$82.8 million in 2023, then rose by 28.19% to -$59.5 million in 2024.